Rankings
▼
Calendar
FTRE
Fortrea Holdings Inc.
$851M
Q2 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$793M
Gross Profit
$155M
19.6% margin
Operating Income
$84M
10.6% margin
Net Income
$66M
8.4% margin
EPS (Diluted)
$0.75
QoQ Revenue Growth
+1.8%
Cash Flow
Operating Cash Flow
$39M
Free Cash Flow
$31M
Stock-Based Comp.
$7M
← FY 2022
All Quarters
Q3 2022 →
FTRE Q2 2022 Earnings — Fortrea Holdings Inc. Revenue & Financial Results | Market Cap Arena
